Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?

by Kathryn A. Mills, Heather Lopez, Lulu Sun, James C. Cripe, Taylor Litz, Premal H. Thaker, Matthew A. Powell, David G. Mutch, Katherine C. Fuh
Published 2019-08-01

Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy.

by Obiageli Ezewuiro, Tatyana A Grushko, Masha Kocherginsky, Mohammed Habis, Jean A Hurteau, Kathryn A Mills, Jessica Hunn, Olufunmilayo I Olopade, Gini F Fleming, Iris L Romero
Published 2016-01-01

Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?

by Brooke Liang, Sara S. Lange, L. Stewart Massad, Rebecca Dick, Kathryn A. Mills, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Katherine C. Fuh, David G. Mutch, Matthew A. Powell, Lindsay M. Kuroki
Published 2019-05-01